UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Environmental Factors Associated With Risk of Crohn’s Disease Development in the Crohn’s and Colitis Canada - Genetic, Environmental, Microbial Project

Clinical gastroenterology and hepatology, 2024-09, Vol.22 (9), p.1889-1897.e12

2024

Volltextzugriff (PDF)

Development and Validation of an Integrative Risk Score for Future Risk of Crohn’s Disease in Healthy First-Degree Relatives: A Multicentre Prospective Cohort Study

Gastroenterology (New York, N.Y. 1943), 2024-08

2024

Volltextzugriff (PDF)

1159 ASSOCIATION OF ULTRA-PROCESSED FOODS WITH GUT MICROBIOME, GUT PERMEABILITY, AND FECAL CALPROTECTIN IN HEALTHY FIRST DEGREE RELATIVE OF CD PATIENTS

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-273-S-273

2024

Volltextzugriff (PDF)

1091 ASSOCIATION OF AIR POLLUTION WITH RISK OF CROHN'S DISEASE AND BIOMARKERS OF CD RISK IN THE CCC-GEM PROJECT

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-261-S-262

2024

Volltextzugriff (PDF)

Tu1897 ASSOCIATION OF ANTI-GRANULOCYTE-MACROPHAGE COLONYSTIMULATING FACTOR ANTIBODIES WITH THE RISK OF CROHN'S DISEASE ONSET AND INTERACTION WITH GUT MICROBIOTA

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1459-S-1459

2024

Volltextzugriff (PDF)

Sa1850 STOOL FROM HEALTHY FIRST DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS WHO LATER DEVELOP CROHN'S DISEASE ALTERS FECAL METABOLITES AND PROMOTES INFLAMMATION IN GERM-FREE MICE

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-550-S-550

2024

Volltextzugriff (PDF)

Perceptions and Prevalence of Cannabis Use in Women With Inflammatory Bowel Disease of Reproductive Age: A Cross-Sectional Study

Journal of the Canadian Association of Gastroenterology, 2024-04, Vol.7 (2), p.204-211

2024

Volltextzugriff (PDF)

Choosing Therapies in Ulcerative Colitis

Journal of the Canadian Association of Gastroenterology, 2024-02, Vol.7 (1), p.9-21

2024

Volltextzugriff (PDF)

Understanding Predictors of Crohn’s Disease: Determinants of Altered Barrier Function in Pre-Disease Phase of Crohn’s Disease

Journal of the Canadian Association of Gastroenterology, 2024-02, Vol.7 (1), p.68-77

2024

Volltextzugriff (PDF)

Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives

Gastroenterology (New York, N.Y. 1943), 2023-09, Vol.165 (3), p.670-681

2023

Volltextzugriff (PDF)

Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis

Gut, 2023-08, Vol.72 (8), p.1462-1471

2023

Volltextzugriff (PDF)

1236 FIRST-DEGREE RELATIVES OF PATIENTS WITH CROHN'S DISEASE FROM MULTIPLEX FAMILIES ARE THREE TIMES MORE LIKELY TO DEVELOP DISEASE AND THIS RISK IS ASSOCIATED WITH SUBCLINICAL INFLAMMATION AND ALTERED MICROBIOME COMPOSITION, BUT NOT GENETIC BURDEN

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-254-S-254

2023

Volltextzugriff (PDF)

Mo1758 PREDICTIVE VALIDLY OF THE TORONTO IBD GLOBAL ENDOSCOPIC REPORTING (TIGER) SCORE FOR CLINICAL OUTCOMES AND QUALITY OF LIFE AMONG ULCERATIVE COLITIS AND CROHN'S DISEASE PATIENTS

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-896-S-896

2023

Volltextzugriff (PDF)

Sa1799 IL-23 RECEPTOR GENETIC VARIANTS ASSOCIATIONS WITH GUT BARRIER FUNCTION AND MICROBIOME COMPOSITON IN A COHORT OF HEALTY FIRST-DEGREE RELATVIES OF SUBJECTS WITH CROHN'S DISEASE

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-437-S-437

2023

Volltextzugriff (PDF)

634 DIETARY ASSOCIATIONS WITH METABOLITES IMPLICATED WITH CROHN'S DISEASE RISK

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-125-S-125

2023

Volltextzugriff (PDF)

1233 BILE ACID COMPOSITION, DIETARY FAT, AND CROHN'S DISEASE RISK

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-253-S-253

2023

Volltextzugriff (PDF)

828 SERUM METABOLOMICS IDENTIFIES DYSREGULATED PATHWAYS AND POTENTIAL METABOLIC BIOMARKERS INVOLVED IN DEVELOPMENT OF CROHN'S DISEASE

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-176-S-176

2023

Volltextzugriff (PDF)

Mo1757 THE TORONTO IBD GLOBAL ENDOSCOPIC REPORTING (TIGER) SCORE AND ITS ABILITY TO PREDICT OUTCOMES REGARDING STEROID AND BIOLOGIC USE IN ULCERATIVE COLITIS AND CROHN'S DISEASE PATIENTS – A CONSTRUCT VALIDATION STUDY

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-896-S-896

2023

Volltextzugriff (PDF)

Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2023-04, Vol.164 (4), p.619-629

2023

Volltextzugriff (PDF)

Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2022-11, Vol.163 (5), p.1364-1376.e10

2022

Volltextzugriff (PDF)

Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation

Gastroenterology (New York, N.Y. 1943), 2022-09, Vol.163 (3), p.685-698

2022

Volltextzugriff (PDF)

Has the Time Come to Say Goodbye to Therapeutic Drug Monitoring As We Know It?

Gastroenterology (New York, N.Y. 1943), 2022-06, Vol.162 (7), p.1831-1832

2022

Volltextzugriff (PDF)

1 – 25 von 350

Suche als RSS-Feed

Aktive Filter

ThemaYoung Adult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(273)
Mit Volltextzugriff
(286)

Publikationsform

Sprache

Englisch
(350)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(126)
Life Sciences & Biomedicine
(125)
Humans
(116)
Gastroenterology & Hepatology
(98)
Inflammatory Bowel Disease
(66)
Gastroenterology And Hepatology
(56)
Adult
(45)
Female
(44)
Male
(44)
Crohn's Disease
(40)
Ulcerative Colitis
(38)
Biological And Medical Sciences
(33)
Gastroenterology
(33)
Medical Sciences
(32)
Middle Aged
(26)
Crohn Disease - Drug Therapy
(25)
Gastroenterology. Liver. Pancreas. Abdomen
(22)
Other Diseases. Semiology
(22)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(22)
Inflammatory Bowel Diseases
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Healthy First-Degree Relatives From Multiplex Families vs Simplex Families Have a Higher Subclinical Intestinal Inflammation, a Distinct Fecal Microbial Signature, and Harbor a Higher Risk of Developing Crohn's Disease

Environmental Factors Associated With Risk of Crohn’s Disease Development in the Crohn’s and Colitis Canada - Genetic, Environmental, Microbial Project

Development and Validation of an Integrative Risk Score for Future Risk of Crohn’s Disease in Healthy First-Degree Relatives: A Multicentre Prospective Cohort Study

1159 ASSOCIATION OF ULTRA-PROCESSED FOODS WITH GUT MICROBIOME, GUT PERMEABILITY, AND FECAL CALPROTECTIN IN HEALTHY FIRST DEGREE RELATIVE OF CD PATIENTS

1091 ASSOCIATION OF AIR POLLUTION WITH RISK OF CROHN'S DISEASE AND BIOMARKERS OF CD RISK IN THE CCC-GEM PROJECT

27 DEVELOPMENT AND VALIDATION OF AN INTEGRATED RISK SCORE FOR PREDICTING FUTURE RISK OF CROHN'S DISEASE UP TO 7 YEARS BEFORE DIAGNOSIS IN HEALTHY FIRST-DEGREE RELATIVES: THE CCCGEM PROJECT, A MULTICENTRE PROSPECTIVE COHORT STUDY

Tu1897 ASSOCIATION OF ANTI-GRANULOCYTE-MACROPHAGE COLONYSTIMULATING FACTOR ANTIBODIES WITH THE RISK OF CROHN'S DISEASE ONSET AND INTERACTION WITH GUT MICROBIOTA

Sa1850 STOOL FROM HEALTHY FIRST DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS WHO LATER DEVELOP CROHN'S DISEASE ALTERS FECAL METABOLITES AND PROMOTES INFLAMMATION IN GERM-FREE MICE

Perceptions and Prevalence of Cannabis Use in Women With Inflammatory Bowel Disease of Reproductive Age: A Cross-Sectional Study

Choosing Therapies in Ulcerative Colitis

Understanding Predictors of Crohn’s Disease: Determinants of Altered Barrier Function in Pre-Disease Phase of Crohn’s Disease

Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives

Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis

1236 FIRST-DEGREE RELATIVES OF PATIENTS WITH CROHN'S DISEASE FROM MULTIPLEX FAMILIES ARE THREE TIMES MORE LIKELY TO DEVELOP DISEASE AND THIS RISK IS ASSOCIATED WITH SUBCLINICAL INFLAMMATION AND ALTERED MICROBIOME COMPOSITION, BUT NOT GENETIC BURDEN

Mo1758 PREDICTIVE VALIDLY OF THE TORONTO IBD GLOBAL ENDOSCOPIC REPORTING (TIGER) SCORE FOR CLINICAL OUTCOMES AND QUALITY OF LIFE AMONG ULCERATIVE COLITIS AND CROHN'S DISEASE PATIENTS

Sa1799 IL-23 RECEPTOR GENETIC VARIANTS ASSOCIATIONS WITH GUT BARRIER FUNCTION AND MICROBIOME COMPOSITON IN A COHORT OF HEALTY FIRST-DEGREE RELATVIES OF SUBJECTS WITH CROHN'S DISEASE

634 DIETARY ASSOCIATIONS WITH METABOLITES IMPLICATED WITH CROHN'S DISEASE RISK

1233 BILE ACID COMPOSITION, DIETARY FAT, AND CROHN'S DISEASE RISK

962 EARLY LIFE EXPOSURE TO PARENTAL CROHN'S DISEASE IS ASSOCIATED WITH ALTERED GUT MICROBIOME COMPOSITION, IMPAIRED GUT PERMEABILITY, AND INCREASED RISK OF INCIDENT CROHN'S DISEASE

828 SERUM METABOLOMICS IDENTIFIES DYSREGULATED PATHWAYS AND POTENTIAL METABOLIC BIOMARKERS INVOLVED IN DEVELOPMENT OF CROHN'S DISEASE

Mo1757 THE TORONTO IBD GLOBAL ENDOSCOPIC REPORTING (TIGER) SCORE AND ITS ABILITY TO PREDICT OUTCOMES REGARDING STEROID AND BIOLOGIC USE IN ULCERATIVE COLITIS AND CROHN'S DISEASE PATIENTS – A CONSTRUCT VALIDATION STUDY

Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis

Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn’s Disease

Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation

Has the Time Come to Say Goodbye to Therapeutic Drug Monitoring As We Know It?

Aktive Filter

Suchergebnisse filtern